Literature DB >> 20932905

Crystal structure of the human collagen XV trimerization domain: a potent trimerizing unit common to multiplexin collagens.

Jacqueline A Wirz1, Sergei P Boudko, Thomas F Lerch, Michael S Chapman, Hans Peter Bächinger.   

Abstract

Correct folding of the collagen triple helix requires a self-association step which selects and binds α-chains into trimers. Here we report the crystal structure of the trimerization domain of human type XV collagen. The trimerization domain of type XV collagen contains three monomers each composed of four β-sheets and an α-helix. The hydrophobic core of the trimer is devoid of solvent molecules and is shaped by β-sheet planes from each monomer. The trimerization domain is extremely stable and forms at picomolar concentrations. It is found that the trimerization domain of type XV collagen is structurally similar to that of type XVIII, despite only 32% sequence identity. High structural conservation indicates that the multiplexin trimerization domain represents a three dimensional fold that allows for sequence variability while retaining structural integrity necessary for tight and efficient trimerization.
Copyright © 2010 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932905      PMCID: PMC3048825          DOI: 10.1016/j.matbio.2010.09.005

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  40 in total

1.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

2.  Drosophila type XV/XVIII collagen, Mp, is involved in Wingless distribution.

Authors:  Ryusuke Momota; Ichiro Naito; Yoshifumi Ninomiya; Aiji Ohtsuka
Journal:  Matrix Biol       Date:  2011-04-06       Impact factor: 11.583

Review 3.  Two new collagen subgroups: membrane-associated collagens and types XV and XVII.

Authors:  T Pihlajaniemi; M Rehn
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

4.  Lack of collagen XVIII/endostatin results in eye abnormalities.

Authors:  Naomi Fukai; Lauri Eklund; Alexander G Marneros; Suk Paul Oh; Douglas R Keene; Lawrence Tamarkin; Merja Niemelä; Mika Ilves; En Li; Taina Pihlajaniemi; Bjorn R Olsen
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

Review 5.  Physiological role of collagen XVIII and endostatin.

Authors:  Alexander G Marneros; Bjorn R Olsen
Journal:  FASEB J       Date:  2005-05       Impact factor: 5.191

Review 6.  Molecular recognition in procollagen chain assembly.

Authors:  S H McLaughlin; N J Bulleid
Journal:  Matrix Biol       Date:  1998-02       Impact factor: 11.583

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 8.  Collagens.

Authors:  Marion K Gordon; Rita A Hahn
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

9.  Identification of a previously unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-helical region.

Authors:  J C Myers; S Kivirikko; M K Gordon; A S Dion; T Pihlajaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 10.  Collagen structure and stability.

Authors:  Matthew D Shoulders; Ronald T Raines
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

View more
  9 in total

1.  Improved stability of multivalent antibodies containing the human collagen XV trimerization domain.

Authors:  Angel M Cuesta; David Sánchez-Martín; Ana Blanco-Toribio; Maider Villate; Kelly Enciso-Álvarez; Ana Alvarez-Cienfuegos; Noelia Sainz-Pastor; Laura Sanz; Francisco J Blanco; Luis Alvarez-Vallina
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  Tumor suppression by collagen XV is independent of the restin domain.

Authors:  Michael J Mutolo; Kirsten J Morris; Shih-Hsing Leir; Thomas C Caffrey; Marzena A Lewandowska; Michael A Hollingsworth; Ann Harris
Journal:  Matrix Biol       Date:  2012-04-16       Impact factor: 11.583

3.  The crystal structure of the streptococcal collagen-like protein 2 globular domain from invasive M3-type group A Streptococcus shows significant similarity to immunomodulatory HIV protein gp41.

Authors:  Flavia Squeglia; Beth Bachert; Alfonso De Simone; Slawomir Lukomski; Rita Berisio
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

4.  The NC2 domain of type IX collagen determines the chain register of the triple helix.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

Review 5.  Collagen XV: exploring its structure and role within the tumor microenvironment.

Authors:  Anthony George Clementz; Ann Harris
Journal:  Mol Cancer Res       Date:  2013-09-16       Impact factor: 5.852

6.  Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis.

Authors:  Jessica J Connelly; Olga A Cherepanova; Jennifer F Doss; Themistoclis Karaoli; Travis S Lillard; Christina A Markunas; Sarah Nelson; Tianyuan Wang; Peter D Ellis; Cordelia F Langford; Carol Haynes; David M Seo; Pascal J Goldschmidt-Clermont; Svati H Shah; William E Kraus; Elizabeth R Hauser; Simon G Gregory
Journal:  Hum Mol Genet       Date:  2013-08-02       Impact factor: 6.150

7.  Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding.

Authors:  Kazunori Mizuno; Sergei Boudko; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

8.  Structural insight for chain selection and stagger control in collagen.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

9.  Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies.

Authors:  Thomas Güttler; Metin Aksu; Antje Dickmanns; Kim M Stegmann; Kathrin Gregor; Renate Rees; Waltraud Taxer; Oleh Rymarenko; Jürgen Schünemann; Christian Dienemann; Philip Gunkel; Bianka Mussil; Jens Krull; Ulrike Teichmann; Uwe Groß; Volker C Cordes; Matthias Dobbelstein; Dirk Görlich
Journal:  EMBO J       Date:  2021-08-09       Impact factor: 14.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.